Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Duchenne
Pharma
Sarepta shares more Elevidys safety data
Eight patients have passed away following treatment with Elevidys, including six unrelated to the gene therapy, Sarepta said.
Angus Liu
Aug 18, 2025 11:32am
With $1B in debts due in 2027, Sarepta weighs efficiency measures
Aug 6, 2025 5:44pm
Patient dies after receiving Sarepta's DMD gene therapy Elevidys
Mar 18, 2025 10:34am
Lawmakers pressure PTC on Emflaza price
Mar 23, 2017 9:08am
Marathon makes surprise deal to sell Emflaza for $140M-plus
Mar 16, 2017 10:40am
Lawmakers pull FDA into the dock over Marathon's Emflaza nod
Mar 15, 2017 4:51pm
